Sodium Butyrate

丁酸钠

Report date: 2023/01/07 17:46:05
NME

Base Information

Drug NameSodium Butyrate
Drug Alias Name正丁酸钠
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsSchizophreniaCognition DisordersHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Mental Health Center
China Registration ClassN/A

Develop Information

Active IndicationsHypertension
Inactive IndicationsSchizophreniaCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A